3-methylcholanthrene has been researched along with trichostatin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abel, J; Förster, I; Fritsche, E; Götz, C; Haarmann-Stemmann, T; Huebenthal, U; Kohne, Z; Krutmann, J; Merk, HF; Tigges, J; Weighardt, H; Wolff, S | 1 |
Chang, CC; Hsu, SP; Huang, KH; Juan, SH; Lee, YG; Sue, YM | 1 |
2 other study(ies) available for 3-methylcholanthrene and trichostatin a
Article | Year |
---|---|
Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression.
Topics: Adult; Animals; Basic Helix-Loop-Helix Transcription Factors; Benzo(a)pyrene; Cells, Cultured; Cytochrome P-450 CYP1A1; Female; Fibroblasts; Gene Expression Regulation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Methylcholanthrene; Mice; Middle Aged; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Repressor Proteins; Skin; Young Adult | 2013 |
Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.
Topics: Carcinogenesis; Cells, Cultured; Epithelial Cells; Epithelial-Mesenchymal Transition; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Hyaluronan Receptors; Hydroxamic Acids; Kidney; Methylcholanthrene; Receptors, Aryl Hydrocarbon; rhoA GTP-Binding Protein; Simvastatin | 2019 |